IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Prosight Management, LP

Q4 2023 Holdings

Filed 2024-02-14 | 35 holdings | $249.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Galapagos ADR REP(GLPG)SPON ADR36315X101$33.6M827,29413.5%
Meiragtx Holdings(MGTX)COMG59665102$28.4M4,050,71411.4%
Shattuck Labs(STTK)COM82024L103$19.8M2,782,7978.0%
Medtronic(MDT)SHSG5960L103$18.1M220,0007.3%
Oric Pharmaceuticals(ORIC)COM68622P109$14.5M1,578,2635.8%
Kura Oncology(KURA)COM50127T109$13.7M950,0005.5%
Biocryst Pharmaceuticals(BCRX)COM09058V103$13.4M2,232,2425.4%
ADC Therapeutics(ADCT)SHSH0036K147$10.7M6,471,8004.3%
Abcellera Biologics(ABCL)COM00288U106$9.7M1,700,0003.9%
Quidelortho(QDEL)COM219798105$8.8M118,9203.5%
Pacira Biosciences(PCRX)COM695127100$8.7M258,4243.5%
Mirum Pharmaceuticals(MIRM)COM604749101$8.7M293,3013.5%
Prothena(PRTA)SHSG72800108$8.3M229,5393.3%
Option Care Health(OPCH)COM NEW68404L201$5.0M148,8002.0%
Galapagos ADR REPCALL36315X901$4.9M120,0002.0%
Neurocrine Biosciences(NBIX)COM64125C109$4.7M35,9001.9%
Universal Health Services CL B(UHS)CL B913903100$4.3M28,0901.7%
Graphite BIO(GRPH)COM38870X104$3.5M1,351,9391.4%
Kezar Life SciencesCOM49372L100$3.2M3,365,3331.3%
Nuvation BIO CL A(NUVB)COM CL A67080N101$3.1M2,050,0001.2%
Orthopediatrics(KIDS)COM68752L100$3.1M95,0001.2%
Privia Health Group(PRVA)COM74276R102$3.0M132,1581.2%
Dexcom(DXCM)COM252131107$2.9M23,0001.1%
Mural OncologyORD SHSG63365103$2.5M418,5051.0%
ProthenaCALLG72800908$1.9M53,5000.8%
Veradigm(MDRX)COM01988P108$1.9M180,0000.8%
Oric PharmaceuticalsCALL68622P909$1.8M200,0000.7%
Barrett Business Services(BBSI)COM068463108$1.5M13,0000.6%
Erasca(ERAS)COM29479A108$1.3M599,4580.5%
Spyre Therapeutics(SYRE)COM NEW00773J202$1.2M55,0000.5%
Shockwave Medical(SWAVUSD)COM82489T104$952.8K5,0000.4%
Design Therapeutics(DSGN)COM25056L103$742.0K280,0000.3%
Biomea Fusion(BMEA)COM09077A106$624.2K42,9910.3%
Alkermes(ALKS)SHSG01767105$416.1K15,0000.2%